NanoKTN Promotes UK Nanotechnology Innovation And MNT Facilities In Europe
Main Category: IT / Internet / E-mailArticle Date: 28 May 2009 - 7:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
The Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK's primary knowledge-based networks for Micro and Nanotechnologies, announced it will be promoting its work at two of Europe's key events in nanotechnology this June. The NanoKTN is calling for all UK MNT companies to get involved and promote their pioneering nanotechnology capabilities to a European audience. The NanoKTN will be present at the EuroNanoForum in Prague 2nd - 5th June and NanoCentral's Annual NanoMaterials Conference in Bonn 16th - 18th June 2009.
The NanoKTN is exhibiting at both the events in Europe and is offering the UK MNT facilities and companies the opportunity to promote their products and work on the NanoKTN's stand. The NanoKTN is encouraging the UK MNT facilities to more actively market the work they do, in order to secure further funding and ensure the UK is kept at the forefront of European nanotechnology innovation.
Alec Reader, Director of the NanoKTN, comments on the importance of these opportunities: "At the NanoKTN, we are dedicated to supporting the growth of UK capabilities and raising the awareness of nanotechnology, both in the UK and Europe. Identifying the UK's potential in innovation by working alongside and supporting the UK MNT facilities and companies is one of the key ways the NanoKTN believes networking opportunities, vital to the further development of nanotechnology, will be created."
Reader continues: "Both the events in Europe are of great importance in the nanotechnology calendar and will be a valuable opportunity to promote the work of the NanoKTN to an international market. I encourage anyone with a desire to drive forward their organisation to get in contact."
Further information about both the EuroNanoForum and the Annual NanoMaterials Conference can be found at http://www.nanoktn.com.
Established by the Technology Strategy Board, the NanoKTN is managed by Centre for Process Innovation Ltd, a leading technology development and consulting company.
About NanoKTN
The NanoKTN facilitates the transfer of knowledge and experience between industry and research, offering companies dealing in small-scale technology access to information on new processes, patents and funding as well as keeping up-to-date with industry regulation. The four broad areas that the NanoKTN focuses on are: Promoting and facilitating knowledge exchange, supporting the growth of UK capabilities, raising awareness of Nanotechnology, and providing thought leadership and input to UK policy and strategy.
About Knowledge Transfer Networks (KTNs)
Knowledge Transfer Networks (KTNs) are national networks in specific fields of technology or business application, which bring together people from businesses, universities, research, finance, the public sector and technology organisations to stimulate innovation through knowledge exchange.
Funded by the Technology Strategy Board, their activities play an increasingly important role in the development of the Government's technology strategy, and help to feed and drive the Collaborative Research & Development Programme and other innovation interventions. There are currently 24 KTNs with a total membership of about 25,000 people.
For further information please see http://www.ktnetworks.co.uk
About CPI
The Centre for Process Innovation (CPI) was established by One NorthEast as a UK wide resource to stimulate and drive innovation within the Process Industry. Working with global industry partners and leading research universities CPI is committed to delivering world-class, groundbreaking applied research and development.
Source
The Technology Strategy Board
Visit our it / internet / e-mail section for the latest news on this subject.
MLA
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/151768.php>
APA
http://www.medicalnewstoday.com/releases/151768.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



